Description
Striatal organoids model the cellular composition and signaling of the human striatum. They enable detailed study of medium spiny neuron development, synaptic integration, and region-specific circuit function. As a result, these human iPSC-derived organoids provide a relevant system for neuroscience research.
Importantly, striatal organoids support evaluation of neurotoxicity, target engagement, and mechanisms of action. They are well suited for studies of Huntington’s disease and other basal ganglia disorders. Because they reflect human biology, these models deliver more predictive translational insights than traditional in vitro systems.
Overall, striatal organoids bridge early-stage research and clinical development. They support the discovery and validation of targeted therapeutic strategies for striatal and basal ganglia diseases.
